Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials by Reith, C

Epidemiological data on the use of traditional anticoagulants in cardiovascular disease by Reith, C, Baigent, C

Individual participant data meta-analysis of new-onset and worsening diabetes mellitus in large-scale randomized double-blind trials of statin therapy by Preiss, D, Reith, C

Protocol for analyses of adverse event data from randomized controlled trials of statin therapy by Mihaylova, B, Reith, C

Randomized clinical trials--removing obstacles. by Reith, C, Landray, M, Califf, R

Accelerating clinical trials: time to turn words into action by Landray, MJ, Haynes, R, Reith, C

Randomized clinical trials--removing obstacles. by Reith, C, Landray, M, Califf, R

Pharmacogenomics of statin therapy: any new insights in efficacy or safety? by Hopewell, J, Reith, C, Armitage, J

Lipid-modifying agents, from statins to PCSK9 inhibitors: JACC focus seminar by Preiss, D, Tobert, JA, Hovingh, GK, Reith, C

Lipid-modifying agents, from statins to PCSK9 inhibitors by Preiss, D, Tobert, J, Hovingh, G, Reith, C

Benefits of lowering cholesterol in chronic kidney disease Reply by Baigent, C, Landray, M, Reith, C, Emberson, J, Collins, R

Angiotensin receptor blockers and β-blockers in Marfan syndrome: an individual-patient-data meta-analysis of randomised trials by Pitcher, A, Spata, E, Emberson, J, Baigent, C, Reith, C

A pragmatic tool for drug discovery by Bobbitt, DR, Merson, L, Reith, C, Bao, W, Okada, M, Facile, R

Assessing baseline medication use in chronic kidney disease: An analysis of the SHARP-ER study by Jun, M, Sukkar, L, Jardine, M, Talbot, B, Cass, A, Reith, C, Walker, R, Gallagher, M

Use of causal diagrams to inform the analysis and interpretation of observational studies: An example from the Study of Heart and Renal Protection (SHARP) by Staplin, N, Herrington, W, Judge, P, Reith, C, Haynes, R, Landray, M, Baigent, C, Emberson, J

Randomized clinical trials--removing unnecessary obstacles. by Reith, C, Landray, M, Devereaux, P, Bosch, J, Granger, C, Baigent, C, Califf, R, Collins, R, Yusuf, S

Efficacy and safety of statin therapy in older people: meta-analysis of individual participant data from 28 randomised controlled trials by Cholesterol Treatment Trialists' Collaboration, Armitage, J, Collins, R, Baigent, C, Barnes, E, Emberson, J, Mihaylova, B, Reith, C

Cost-effectiveness of lowering LDL cholesterol with statins and ezetimibe in chronic kidney disease by Mihaylova, B, Kent, S, Herrington, W, Emberson, J, Haynes, R, Reith, C, Collins, R, Landray, M, Gray, A, Baigent, C

Cause of death varies across Australia, New Zealand and Malaysia in those on renal replacement therapy - Results from the Study of Heart And Renal Protection-Extended Review (SHARP... by Talbot, B, Sukkar, L, Smyth, B, Jun, M, Jardine, M, Cass, A, Walker, R, Reith, C, Hooi, L, Gallagher, M

Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trials by Staplin, N, Roddick, AJ, Emberson, J, Reith, C, Riding, A, Wonnacott, A, Kuverji, A, Bhandari, S, Baigent, C, Haynes, R, Herrington, WG